Disclosures for "Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20 "
-
Ms. Divino has received personal compensation for serving as an employee of IQVIA.
-
Dr. Mallick has received personal compensation for serving as an employee of CSL Behring.
-
Ms. Lahue has received personal compensation for serving as an employee of Alkemi . An immediate family member of Ms. Lahue has received personal compensation for serving as an employee of Alkemi. Ms. Lahue has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for EvoEndo. An immediate family member of Ms. Lahue has stock in Pfizer.
-
Ms. Coyle has received personal compensation for serving as an employee of IQVIA.
-
Ms. Wang has received personal compensation for serving as an employee of IQVIA.
-
Mr. Dekoven has received personal compensation for serving as an employee of IQVIA.
-
Alphonse Hubsch has received personal compensation for serving as an employee of CSL Behring. Alphonse Hubsch has stock in CSL Behring .